Bioventus outlines 2026 adjusted EPS of $0.75-$0.79 while reaffirming $600M-$610M revenue
Bioventus Inc. Class A Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $7.93
-6.7% in 3d after detection
Post-detection moves
1h
—
1d
-2.5%
3d
-6.7%
7d
-3.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS